136 related articles for article (PubMed ID: 7652856)
21. A negative T cell crossmatch is adequate to permit successful renal transplantation.
Lowry RP; Myrberg S; Goguen JE; Carpenter CB; Cho S; Garovoy MR
Proc Clin Dial Transplant Forum; 1979; 9():201-4. PubMed ID: 399507
[No Abstract] [Full Text] [Related]
22. Value of flow cytometric monitoring of posttransplant antibody status in renal transplantation.
al-Hussein KA; Shenton BK; Bell A; Talbot D; White MD; Clark KR; Rigg KM; Forsythe J; Proud G; Taylor RM
Transplant Proc; 1993 Feb; 25(1 Pt 1):259-61. PubMed ID: 8438293
[No Abstract] [Full Text] [Related]
23. Renal allograft survival in CSA-treated patients with positive donor-specific B cell crossmatches.
Noreen HJ; van der Hagen E; Bach FH; Najarian JS; Fryd DS
Transplant Proc; 1989 Feb; 21(1 Pt 1):691-2. PubMed ID: 2650224
[No Abstract] [Full Text] [Related]
24. Outcome of donor specific transfusion renal transplants across B cell positive crossmatches.
Balakrishnan K; Munda R; First MR; Alexander JW
Transplant Proc; 1989 Feb; 21(1 Pt 2):1836. PubMed ID: 2652597
[No Abstract] [Full Text] [Related]
25. T-cell flow-cytometry crossmatch and long-term renal graft survival.
Rebibou JM; Bittencourt MC; Saint-Hillier Y; Chabod J; Dupont I; Bittard H; Chalopin JM; Hervé P; Tiberghien P
Clin Transplant; 2004 Oct; 18(5):558-63. PubMed ID: 15344960
[TBL] [Abstract][Full Text] [Related]
26. Plasma exchange and immunosuppressive therapy before renal transplantation in highly sensitized patients.
Fauchald P; Leivestad T; Bratlie A; Jakobsen A; Flatmark A
Transplant Proc; 1987 Feb; 19(1 Pt 1):727-8. PubMed ID: 3274854
[No Abstract] [Full Text] [Related]
27. Preexisting antibodies: the clinical relevance of auto-B-lymphocyte antibody and positive B-cell crossmatch.
Mongkolsuk T; Chiewsilp P; Sujirachato K; Sumethkul V; Jirasiritham S; Chalermsanyakorn P; Danviriyasup K
Transplant Proc; 1996 Jun; 28(3):1215-6. PubMed ID: 8658631
[No Abstract] [Full Text] [Related]
28. B-cell flow-cytometry crossmatch: influence in renal transplantation.
De Carvalho Bittencourt M; Saint-Hillier Y; Chabod J; Dupont I; Chalopin JM; Hervé P; Tiberghien P
Transplant Proc; 1997; 29(1-2):1456-7. PubMed ID: 9123379
[No Abstract] [Full Text] [Related]
29. Cytotoxic crossmatches in renal transplant patients by conventional cytotoxicity, immunomagnetic cell separation, and flow cytometry.
Horsburgh T; Mistry N; Sidgwick A; Bell PR
Transplant Proc; 1990 Aug; 22(4):1899. PubMed ID: 2389479
[No Abstract] [Full Text] [Related]
30. [The prognostic significance of pre-existing lymphocytotoxic antibodies in cadaveric kidney allografts with a negative specific crossmatch].
Kharlamova LA; Zemlianitskaia TL; Makhlin NV; Iankovoĭ
Urol Nefrol (Mosk); 1993; (4):30-2. PubMed ID: 8310563
[TBL] [Abstract][Full Text] [Related]
31. Clinical implications of flow cytometry B cell crossmatching in renal transplantation.
Kotb M; Russel W; Ohman M; Hathaway D; Gaber AO
Transplant Proc; 1997; 29(1-2):1430-2. PubMed ID: 9123367
[No Abstract] [Full Text] [Related]
32. Clinical relevance of low levels of preformed alloantibodies detected by flow cytometry in the first year post-kidney transplantation.
Michelon T; Schroeder R; Fagundes I; Canabarro R; Sporleder H; Rodrigues H; Silveira J; Montagner J; Garcia V; Neumann J; Graudenz M
Transplant Proc; 2005; 37(6):2750-2. PubMed ID: 16182800
[TBL] [Abstract][Full Text] [Related]
33. Improved graft survival with donor-specific transfusion pretreatment.
Cochrum K; Hanes D; Potter D; Perkins H; Amend W; Vincenti F; Iwaki Y; Opelz G; Terasaki P; Feduska N; Salvatierra O
Transplant Proc; 1981 Mar; 13(1 Pt 1):190-3. PubMed ID: 7022820
[No Abstract] [Full Text] [Related]
34. Flow cytometry crossmatching (FCXM) in the UNOS Kidney Transplant Registry.
Cook DJ; Fettouh HI; Gjertson DW; Cecka JM
Clin Transpl; 1998; ():413-9. PubMed ID: 10503119
[TBL] [Abstract][Full Text] [Related]
35. Quantitative flow cytometry cross-matching for precise measurement of donor-specific alloreactivity.
Cook DJ; Klingman LL; Koo AP; Goldfarb D; Dennis VW; Hodge EE
Transplant Proc; 1994 Oct; 26(5):2866-7. PubMed ID: 7940904
[No Abstract] [Full Text] [Related]
36. Interaction between panel reactive antibodies, auto- and cold reactive antibodies, and a positive B cell cross-match in renal and cardiac allograft survival.
Creemers P; Brink J; Kahn D
Clin Transplant; 1997 Apr; 11(2):134-8. PubMed ID: 9113450
[TBL] [Abstract][Full Text] [Related]
37. Graft outcome in the multiple transplant patient with a positive donor cross-match with non-current sera.
Falk JA; Cardella CJ; Halloran PF; Bear RA; Arbus GS
Transplant Proc; 1987 Feb; 19(1 Pt 1):721-2. PubMed ID: 3274852
[No Abstract] [Full Text] [Related]
38. Impact of flow cytometry cross-matching results on the outcome of cadaveric kidney transplantation.
Wahlberg J; Bengtsson M; Bergström C; Gannedahl G; Festin R; Lewen G; Frödin L
Transplant Proc; 1994 Jun; 26(3):1752-3. PubMed ID: 8030118
[No Abstract] [Full Text] [Related]
39. Strong impact of HLA-DR-matching on graft survival in 413 consecutive cadaver kidney transplants performed in Copenhagen over an eight-year period.
Jakobsen BK; Ryder LP; Ladefoged J; Løkkegaard H; Nielsen B; Olgaard K; Svejgaard A
Transplant Proc; 1995 Dec; 27(6):3452-3. PubMed ID: 8540048
[No Abstract] [Full Text] [Related]
40. DNA heteroduplex analysis reveals mismatching of DR alleles in HLA-DR serologically matched cadaveric renal transplantation.
Connolly J; Sinnott PJ; Ivinson AJ; Parrott NR; Martin S; Dyer PA
Transplant Proc; 1993 Dec; 25(6):3064. PubMed ID: 7903497
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
